Antibodies made in 98pc of AstraZeneca vaccine recipients

BSMMU study

Staff Correspondent: Antibodies have been found in 98 percent of Oxford-AstraZeneca vaccine recipients in the country.
The information came up in a study on vaccines published by Bangabandhu Sheikh Mujib University (BSMMU) at 11 am yesterday.
It also found the presence of antibodies is “higher” among those who were contracted Covid-19 before and taking the jab after recovery.
Vaccination activities began with Covishield, originally invented by Oxford University and manufactured at the Serum Institute, India, the study said, informing that several other types of vaccines are currently being used in the vaccination program. “The purpose of vaccination is to produce antibodies against the coronavirus in the human body, which reduces the risk of contracting Covid-19 in the future and the severity of the disease if infected,” the study also said.
According to the research report, there is no alternative to the COVID vaccination program. There is also a need to ensure proper hygiene in all necessary cases.
The study titled ‘Haematological Parameters and Antibody Titre After Vaccination Against SARS-CoV-2’ was led by Prof. Dr. Md. Sharfuddin Ahmed, Vice Chancellor (VC) of BSMMU. Besides, Prof. Dr. Zahid Hossain, Pro-VC (Research and Development) of BSMMU, Prof. Dr. AKM Mosharraf Hossain, Pro-VC (Education) and Prof. Dr. Md. Salahuddin Shah, chairman of BSMMU’s Hematology department, were involved in the project as co-researchers.
From April to July this year, 209 people who received the Covid-19 vaccine volunteered for the study. More than 31 percent of participants had a history of contracting Covid-19. More than half of the participants were already suffering from diabetes, high blood pressure, asthma and other diseases.
However, in most cases due to such diseases, there was no difference in the production of antibodies after vaccination. 42 percent of the participants reported “side effects” after receiving the vaccine.
Besides, all of them had mild symptoms of Covid-19. Blood clots or any other complicated side effects were not observed during the study.